Cambridge-based unicorn CMR Surgical, a surgical equipment manufacturer, announced that it has raised €154.7M in a fresh round of funding.
Ally Bridge Group, Cambridge Innovation Capital, Escala Capital, LGT, Lightrock, RPMI Railpen, SoftBank Vision Fund 2, Tencent, and Watrium participated in the founding round.
The company also announced that its Versius Surgical Robotic System has completed over 15,000 surgeries worldwide. The surgeries include complicated procedures for hernia repairs, colectomies, hysterectomies, sacrocolpopexies, and lobectomies.
Versius is a small-sized modular surgical system for minimal access surgery (MAS). CMR achieved Unicorn status in 2019 when its value exceeded €938.6M.
Hospitals of varying sizes around the world have used Versius for numerous medical surgeries. These include the UK’s Royal Papworth Hospital, NHS Foundation Trust and Germany’s Klinikum Chemnitz GmbH.
CMR Surgical says it is going to use the fresh funds to continue product innovation, including new technological developments. The company also aims to commercialise the use of Versius in new locations.
Positive reception from health institutions
Officials from CMR Surgical, as well as Versius using health institutions, have expressed positive opinions concerning the MAS system.
“Versius is very well suited to our needs as a world-leading thoracic surgery department. We have successfully helped patients get the benefit of robotic-assisted surgery, and we look forward to developing our robotics programme working with CMR and other centres around the world as the adoption of Versius continues,” says Adam Peryt, consultant thoracic surgeon at Royal Papworth Hospital.
Supratim Bose, chief executive officer at CMR Surgical, says, “I am incredibly proud of our teams and what CMR stands for as we pass this latest milestone and work towards our vision of making minimal access surgery available to everyone.”
“The benefits of MAS for patients are enormous, and I am excited to see the continued adoption of Versius around the world, and the positive impact it is having on hospitals, surgeons, and, ultimately, their patients,” adds Bose.
CMR Surgical (CMR) is a Cambridge-based global medical devices company dedicated to transforming surgery with its next-generation surgical robot Versius.
Founded in 2014, CMR actively cooperates with surgeons, surgical teams, and Hospital partners to make MAS affordable and accessible. Today, Versius sees widespread use in the UK, Europe, Latin America, the Middle East, Asia, and Africa.
With Versius, CMR aims to transform the surgical robotics market with evidence-based technology and data.
In revolutionising the surgical robotics market, CMR is also an Official Medical Device Partner of ParalympicsGB. The company emphasises medical precision and control to assist Paralympians.
This partnership aligns with CMR’s objective to ensure MAS is affordable and accessible for everyone regardless of background.